A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate and compare the relative bioavailability of Quinine
Sulfate 324 mg capsules, manufactured by the Mutual Pharmaceutical Company, to Quinine
Sulphate 300 mg tablets, manufactured by the Government Pharmaceutical Organization, Bangkok
Metropolis, Thailand, after single oral dose administration under fasting conditions. An
additional purpose of this study is to evaluate the effect of food on the Mutual
Pharmaceutical Company product.